Company · CIK 0000884731 · SIC 2836 — Biological Products, (No Diagnostic Substances)
ARIAD PHARMACEUTICALS INC · ARIA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2017 DForm 4 → | Feb 16, 2:18 pm EST | Timothy P ClacksonPresident, R&D, CSO | 220,444 | — | — | 0 | — | plan? |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:17 pm EST | Jules HaimovitzDirector | 18,008 | — | — | 0 | — | plan? |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:17 pm EST | George BickerstaffDirector | 18,008 | — | — | 0 | — | plan? |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:17 pm EST | Jennifer Lyn HerronExec V.P. Chief Comm'l Officer | 450 | — | — | 0 | — | plan? |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:16 pm EST | Hugh M ColeSVP, Chief Business Officer | 42,834 | — | — | 0 | — | plan? |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:16 pm EST | Norbert G RiedelDirector | 139,867 | — | — | 0 | — | plan? |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:15 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 126,352 | — | — | 0 | — | plan? |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:15 pm EST | Paris PanayiotopoulosPresident and CEO, Director | 159,378 | — | — | 0 | — | plan? |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:15 pm EST | Anna ProtopapasDirector | 41,910 | — | — | 0 | — | plan? |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:14 pm EST | Manmeet Singh SoniEVP, CFO & Treasurer | 3,273 | — | — | 0 | — | plan? |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:14 pm EST | Alexander J DennerDirector | 12,903,173 | — | — | 0 | — | plan? |
| Feb 13, 2017 DGForm 4 → | Feb 16, 2:18 pm EST | Sarah J. SchlesingerDirector | 71,108 | — | — | 0 | — | plan? late |
| Jan 31, 2017 FMForm 4 → | Feb 2, 4:42 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 44,000 | $23.81 | $349,293 | 126,352 | — | plan? |
| Jan 31, 2017 FMForm 4 → | Feb 2, 4:41 pm EST | Timothy P ClacksonPresident, R&D, CSO | 38,943 | $23.82 | $228,886 | 219,867 | — | plan? |
| Jan 31, 2017 AForm 4 → | Feb 2, 9:39 am EST | Alexander J DennerDirector | 18,008 | — | — | 53,173 | — | plan? |
| Jan 31, 2017 AForm 4 → | Feb 1, 4:56 pm EST | George BickerstaffDirector | 18,008 | — | — | 18,008 | — | plan? |
| Jan 31, 2017 AForm 4 → | Feb 1, 4:56 pm EST | Sarah J. SchlesingerDirector | 18,008 | — | — | 55,508 | — | plan? |
| Jan 31, 2017 AForm 4 → | Feb 1, 4:55 pm EST | Jules HaimovitzDirector | 18,008 | — | — | 18,008 | — | plan? |
| Jan 31, 2017 AForm 4 → | Feb 1, 4:55 pm EST | Norbert G RiedelDirector | 18,008 | — | — | 139,867 | — | plan? |
| Jan 31, 2017 AForm 4 → | Feb 1, 4:54 pm EST | Anna ProtopapasDirector | 18,008 | — | — | 41,910 | — | plan? |
| Jan 13, 2017 FMForm 4 → | Jan 17, 5:06 pm EST | Paris PanayiotopoulosPresident and CEO, Director | 99,900 | $23.69 | $788,934 | 159,378 | — | plan? |
| Jan 9, 2017 SForm 4 → | Jan 10, 6:17 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 32,000 | $23.78 | $760,960 | 129,404 | −19.8% | plan? |
| Jan 9, 2017 MForm 4 → | Jan 10, 6:17 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 32,000 | $7.82 | $250,240 | 161,404 | — | plan? |
| Oct 24, 2016 SForm 4 → | Oct 25, 4:07 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 19,638 | $9.56 | $187,739 | 197,884 | −9.03% | plan? |
| Oct 3, 2016 SForm 4 → | Oct 5, 4:17 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 47,384 | $13.46 | $637,812 | 129,404 | −26.8% | plan? |
| Sep 28, 2016 SForm 4 → | Sep 28, 4:19 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 8,750 | $13.98 | $122,311 | 217,522 | −3.87% | plan? |
| Sep 26, 2016 MForm 4 → | Sep 28, 4:20 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 10,000 | — | — | 176,788 | — | plan? |
| Sep 26, 2016 MForm 4 → | Sep 28, 4:19 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 17,500 | — | — | 226,272 | — | plan? |
| Sep 22, 2016 SForm 4 → | Sep 23, 5:46 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 20,000 | $13.43 | $268,536 | 208,772 | −8.74% | plan? |
| Sep 15, 2016 SForm 4 → | Sep 16, 5:08 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 59,369 | $11.73 | $696,398 | 228,772 | −20.6% | plan? |
| Sep 15, 2016 MForm 4 → | Sep 16, 5:08 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 59,369 | $7.82 | $464,266 | 288,141 | — | plan? |
| Aug 22, 2016 SForm 4 → | Aug 23, 4:12 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 19,436 | $10.47 | $203,538 | 228,772 | −7.83% | plan? |
| Aug 12, 2016 SForm 4 → | Aug 15, 4:16 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 25,000 | $10.50 | $262,500 | 248,208 | −9.15% | plan? |
| Aug 12, 2016 MForm 4 → | Aug 15, 4:16 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 25,000 | $7.69 | $192,250 | 273,208 | — | plan? |
| Jul 22, 2016 SForm 4 → | Jul 25, 4:39 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 18,286 | $8.11 | $148,230 | 248,208 | −6.86% | plan? |
| Jul 13, 2016 FMForm 4 → | Jul 14, 4:23 pm EDT | Paris PanayiotopoulosPresident and CEO, Director | 95,211 | $7.14 | $204,283 | 126,078 | — | plan? |
| Jul 1, 2016 SForm 4 → | Jul 5, 4:07 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 61,422 | $7.48 | $459,634 | 266,494 | −18.7% | plan? |
| Jul 1, 2016 MForm 4 → | Jul 5, 4:07 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 61,422 | $3.88 | $238,585 | 296,494 | — | plan? |
| Jun 28, 2016 SForm 4 → | Jun 29, 4:25 pm EDT | Hugh M ColeSVP, Chief Business Officer | 6,012 | $7.05 | $42,385 | 29,916 | −16.7% | plan? |
| Jun 27, 2016 MForm 4 → | Jun 29, 4:25 pm EDT | Hugh M ColeSVP, Chief Business Officer | 19,166 | — | — | 35,928 | — | plan? |
| Jun 22, 2016 SForm 4 → | Jun 23, 4:11 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 23,999 | $7.28 | $174,638 | 264,742 | −8.31% | plan? |
| Jun 13, 2016 SForm 4 → | Jun 15, 4:19 pm EDT | Athanese LavidasDirector | 76,250 | $8.21 | $626,039 | 131,631 | −36.7% | plan? |
| Jun 13, 2016 MForm 4 → | Jun 15, 4:19 pm EDT | Athanese LavidasDirector | 76,250 | $6.38 | $486,488 | 177,881 | — | plan? |
| Jun 10, 2016 SForm 4 → | Jun 14, 6:13 pm EDT | Massimo RadaelliDirector | 108,569 | $8.25 | $896,135 | 105,500 | −50.7% | plan? |
| Jun 10, 2016 MForm 4 → | Jun 14, 6:13 pm EDT | Massimo RadaelliDirector | 108,569 | $5.39 | $584,733 | 111,750 | — | plan? |
| May 23, 2016 SForm 4 → | May 25, 4:04 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 17,762 | $8.08 | $143,430 | 288,741 | −5.80% | plan? |
| May 12, 2016 PForm 4 → | May 13, 5:59 pm EDT | Paris PanayiotopoulosPresident and CEO, Director | 26,990 | $7.41 | $199,996 | 88,089 | +44.2% | plan? |
| May 2, 2016 SForm 4 → | May 2, 5:28 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 11,700 | $7.13 | $83,478 | 306,503 | −3.68% | plan? |
| Apr 29, 2016 FMForm 4 → | May 2, 5:33 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 22,968 | $7.18 | $40,452 | 158,711 | — | plan? |
| Apr 29, 2016 FMForm 4 → | May 2, 5:32 pm EDT | Maria E CantorSVP, Corporate Affairs | 17,668 | $7.18 | $31,118 | 144,667 | — | plan? |
| Apr 29, 2016 FMForm 4 → | May 2, 5:30 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 22,968 | $7.18 | $40,452 | 166,788 | — | plan? |
| Apr 29, 2016 FMForm 4 → | May 2, 5:29 pm EDT | Hugh M ColeSVP, Chief Business Officer | 22,968 | $7.18 | $40,452 | 16,762 | — | plan? |
| Apr 29, 2016 MForm 4 → | May 2, 5:28 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 23,400 | — | — | 318,203 | — | plan? |
| Apr 29, 2016 FMForm 4 → | May 2, 5:26 pm EDT | Martin J DuvallEVP, CCO | 23,850 | $7.18 | $42,003 | 105,189 | — | plan? |
| Apr 22, 2016 SForm 4 → | Apr 25, 4:04 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 21,409 | $7.37 | $157,864 | 294,803 | −6.77% | plan? |
| Mar 22, 2016 SForm 4 → | Mar 23, 4:41 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 23,834 | $6.58 | $156,871 | 316,212 | −7.01% | plan? |
| Mar 21, 2016 SForm 4 → | Mar 22, 4:02 pm EDT | David L BersteinSVP, Chief IP Counsel | 2,375 | $6.47 | $15,356 | 262,115 | −0.90% | plan? |
| Mar 21, 2016 SForm 4 → | Mar 22, 4:02 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 4,000 | $6.47 | $25,871 | 155,088 | −2.51% | plan? |
| Mar 21, 2016 SForm 4 → | Mar 22, 4:01 pm EDT | Edward M FitzgeraldExecutive VP | 5,417 | $6.47 | $35,037 | 320,367 | −1.66% | plan? |
| Mar 21, 2016 SForm 4 → | Mar 22, 4:01 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 3,575 | $6.47 | $23,116 | 147,011 | −2.37% | plan? |
| Mar 19, 2016 SForm 4 → | Mar 22, 4:03 pm EDT | Martin J DuvallEVP, CCO | 4,000 | $6.47 | $25,867 | 93,039 | −4.12% | plan? |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:03 pm EDT | Martin J DuvallEVP, CCO | 8,000 | — | — | 97,039 | — | plan? |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:02 pm EDT | David L BersteinSVP, Chief IP Counsel | 4,750 | — | — | 264,490 | — | plan? |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:02 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 8,000 | — | — | 159,088 | — | plan? |
| Mar 19, 2016 SForm 4 → | Mar 22, 4:02 pm EDT | Maria E CantorSVP, Corporate Affairs | 3,575 | $6.46 | $23,102 | 135,667 | −2.57% | plan? |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:02 pm EDT | Maria E CantorSVP, Corporate Affairs | 6,500 | — | — | 139,242 | — | plan? |
| Mar 19, 2016 SForm 4 → | Mar 22, 4:01 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 5,417 | $6.47 | $35,039 | 340,046 | −1.57% | plan? |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:01 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 10,833 | — | — | 345,463 | — | plan? |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:01 pm EDT | Edward M FitzgeraldExecutive VP | 10,833 | — | — | 325,784 | — | plan? |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:01 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 6,500 | — | — | 150,586 | — | plan? |
| Mar 16, 2016 FMForm 4 → | Mar 18, 4:04 pm EDT | Hugh M ColeSVP, Chief Business Officer | 9,938 | $6.21 | $61,715 | 5,062 | — | plan? |
| Mar 15, 2016 DMForm 4 → | Mar 17, 4:45 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 26,564 | $5.49 | $145,884 | 132,024 | — | plan? |
| Mar 3, 2016 SForm 4 → | Mar 3, 8:12 pm EST | Edward M FitzgeraldExecutive VP, CFO | 9,625 | $6.12 | $58,866 | 314,951 | −2.97% | plan? |
| Mar 3, 2016 SForm 4 → | Mar 3, 8:08 pm EST | David L BersteinSVP, Chief IP Counsel | 9,625 | $6.12 | $58,887 | 259,740 | −3.57% | plan? |
| Mar 3, 2016 SForm 4 → | Mar 3, 8:07 pm EST | Martin J DuvallEVP, CCO | 9,625 | $6.12 | $58,863 | 89,039 | −9.76% | plan? |
| Mar 3, 2016 SForm 4 → | Mar 3, 8:00 pm EST | Maria E CantorSVP, Corporate Affairs | 9,625 | $6.12 | $58,869 | 132,742 | −6.76% | plan? |
| Mar 3, 2016 SForm 4 → | Mar 3, 7:59 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 9,625 | $6.11 | $58,852 | 151,088 | −5.99% | plan? |
| Mar 3, 2016 SForm 4 → | Mar 3, 7:58 pm EST | Frank HaluskaSVP, Clinical R&D, CMO | 10,588 | $6.11 | $64,733 | 144,086 | −6.85% | plan? |
| Mar 2, 2016 SForm 4 → | Mar 3, 8:00 pm EST | Timothy P ClacksonPresident, R&D, CSO | 34,672 | $6.03 | $209,149 | 334,630 | −9.39% | plan? |
| Mar 1, 2016 MForm 4 → | Mar 3, 8:12 pm EST | Edward M FitzgeraldExecutive VP, CFO | 19,250 | — | — | 324,576 | — | plan? |
| Mar 1, 2016 MForm 4 → | Mar 3, 8:08 pm EST | David L BersteinSVP, Chief IP Counsel | 19,250 | — | — | 269,365 | — | plan? |
| Mar 1, 2016 MForm 4 → | Mar 3, 8:07 pm EST | Martin J DuvallEVP, CCO | 19,250 | — | — | 98,664 | — | plan? |
| Mar 1, 2016 MForm 4 → | Mar 3, 8:00 pm EST | Maria E CantorSVP, Corporate Affairs | 19,250 | — | — | 142,367 | — | plan? |
| Mar 1, 2016 MForm 4 → | Mar 3, 8:00 pm EST | Timothy P ClacksonPresident, R&D, CSO | 19,250 | — | — | 369,302 | — | plan? |
| Mar 1, 2016 MForm 4 → | Mar 3, 7:59 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 19,250 | — | — | 160,713 | — | plan? |
| Mar 1, 2016 MForm 4 → | Mar 3, 7:58 pm EST | Frank HaluskaSVP, Clinical R&D, CMO | 19,250 | — | — | 154,674 | — | plan? |
| Feb 18, 2016 FMForm 4 → | Mar 30, 5:04 pm EDT | Thomas DesRosierEVP, General Counsel | 73,370 | $5.03 | $92,401 | 36,630 | — | plan? late |
| Feb 1, 2016 AForm 4/A → | Feb 9, 5:31 pm EST | Jay R LamarcheDirector | 12,500 | — | — | 552,205 | — | plan? |
| Feb 1, 2016 PForm 4 → | Feb 3, 5:43 pm EST | Paris PanayiotopoulosPresident and CEO, Director | 61,099 | $4.91 | $299,996 | 61,099 | — | plan? |
| Feb 1, 2016 AForm 4 → | Feb 3, 5:31 pm EST | Alexander J DennerDirector | 12,500 | — | — | 35,165 | — | plan? |
| Feb 1, 2016 AForm 4 → | Feb 3, 5:17 pm EST | Jay R LamarcheDirector | 12,500 | — | — | 452,205 | — | plan? amended |
| Feb 1, 2016 AForm 4 → | Feb 3, 5:15 pm EST | Wayne WilsonDirector | 12,500 | — | — | 125,500 | — | plan? |
| Feb 1, 2016 AForm 4 → | Feb 3, 5:08 pm EST | Athanese LavidasDirector | 12,500 | — | — | 131,631 | — | plan? |
| Feb 1, 2016 AForm 4 → | Feb 3, 4:56 pm EST | Anna ProtopapasDirector | 23,902 | — | — | 23,902 | — | plan? |
| Feb 1, 2016 AForm 4 → | Feb 3, 4:54 pm EST | Massimo RadaelliDirector | 12,500 | — | — | 105,500 | — | plan? |
| Feb 1, 2016 AForm 4 → | Feb 3, 4:50 pm EST | Sarah J. SchlesingerDirector | 12,500 | — | — | 37,500 | — | plan? |
| Feb 1, 2016 AForm 4 → | Feb 3, 4:47 pm EST | Norbert G RiedelDirector | 12,500 | — | — | 121,859 | — | plan? |
| Feb 1, 2016 SForm 4 → | Feb 3, 4:46 pm EST | Martin J DuvallEVP, CCO | 14,667 | $4.81 | $70,578 | 79,414 | −15.6% | plan? |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:46 pm EST | Martin J DuvallEVP, CCO | 29,333 | — | — | 94,081 | — | plan? |
| Feb 1, 2016 SForm 4 → | Feb 3, 4:43 pm EST | Timothy P ClacksonPresident, R&D, CSO | 14,667 | $4.81 | $70,517 | 350,052 | −4.02% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 16, 2017 DForm 4 → | Feb 16, 2:18 pm EST | Sarah J. SchlesingerDirector | 140,000 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:18 pm EST | Timothy P ClacksonPresident, R&D, CSO | 321,655 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:17 pm EST | Jules HaimovitzDirector | 100,000 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:17 pm EST | George BickerstaffDirector | 100,000 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:17 pm EST | Jennifer Lyn HerronExec V.P. Chief Comm'l Officer | 305,291 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:16 pm EST | Hugh M ColeSVP, Chief Business Officer | 252,521 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:16 pm EST | Jayne M. GanslerSenior V.P. Human Resources | 218,910 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:16 pm EST | Norbert G RiedelDirector | 125,000 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:15 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 202,105 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:15 pm EST | Paris PanayiotopoulosPresident and CEO, Director | 1,566,800 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:15 pm EST | Anna ProtopapasDirector | 125,000 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:14 pm EST | Manmeet Singh SoniEVP, CFO & Treasurer | 557,937 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:14 pm EST | Elona Kogan Esq.Sr. V. P. - General Counsel | 306,085 | — | — | 0 | — | |
| Feb 16, 2017 DForm 4 → | Feb 16, 2:14 pm EST | Alexander J DennerDirector | 8,950,000 | — | — | 0 | — | |
| Feb 6, 2017 AForm 4 → | Feb 7, 4:59 pm EST | Elona Kogan Esq.Sr. V. P. - General Counsel | 6,085 | — | — | 6,085 | — | |
| Feb 6, 2017 AForm 4 → | Feb 7, 4:58 pm EST | Manmeet Singh SoniEVP, CFO & Treasurer | 7,937 | — | — | 7,937 | — | |
| Feb 6, 2017 AForm 4 → | Feb 7, 4:58 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 3,439 | — | — | 3,439 | — | |
| Feb 6, 2017 AForm 4 → | Feb 7, 4:58 pm EST | Timothy P ClacksonPresident, R&D, CSO | 14,550 | — | — | 14,550 | — | |
| Feb 6, 2017 AForm 4 → | Feb 7, 4:57 pm EST | Jayne M. GanslerSenior V.P. Human Resources | 2,910 | — | — | 2,910 | — | |
| Feb 6, 2017 AForm 4 → | Feb 7, 4:57 pm EST | Jennifer Lyn HerronExec V.P. Chief Comm'l Officer | 5,291 | — | — | 5,291 | — | |
| Jan 31, 2017 MForm 4 → | Feb 2, 4:42 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 29,333 | — | — | 0 | — | |
| Jan 31, 2017 MForm 4 → | Feb 2, 4:41 pm EST | Timothy P ClacksonPresident, R&D, CSO | 29,333 | — | — | 0 | — | |
| Jan 31, 2017 AForm 4 → | Feb 2, 9:39 am EST | Alexander J DennerDirector | 25,000 | $23.82 | $595,500 | 25,000 | — | |
| Jan 31, 2017 AForm 4 → | Feb 1, 4:56 pm EST | George BickerstaffDirector | 25,000 | $23.82 | $595,500 | 25,000 | — | |
| Jan 31, 2017 AForm 4 → | Feb 1, 4:56 pm EST | Sarah J. SchlesingerDirector | 25,000 | $23.82 | $595,500 | 25,000 | — | |
| Jan 31, 2017 AForm 4 → | Feb 1, 4:55 pm EST | Jules HaimovitzDirector | 25,000 | $23.82 | $595,500 | 25,000 | — | |
| Jan 31, 2017 AForm 4 → | Feb 1, 4:55 pm EST | Norbert G RiedelDirector | 25,000 | $23.82 | $595,500 | 25,000 | — | |
| Jan 31, 2017 AForm 4 → | Feb 1, 4:54 pm EST | Anna ProtopapasDirector | 25,000 | $23.82 | $595,500 | 25,000 | — | |
| Jan 13, 2017 MForm 4 → | Jan 17, 5:06 pm EST | Paris PanayiotopoulosPresident and CEO, Director | 66,600 | — | — | 66,800 | — | |
| Jan 9, 2017 MForm 4 → | Jan 10, 6:17 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 32,000 | — | — | 0 | — | |
| Sep 26, 2016 MForm 4 → | Sep 28, 4:20 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 10,000 | — | — | 0 | — | |
| Sep 26, 2016 MForm 4 → | Sep 28, 4:19 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 17,500 | — | — | 0 | — | |
| Sep 15, 2016 MForm 4 → | Sep 16, 5:08 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 59,369 | — | — | 0 | — | |
| Aug 12, 2016 MForm 4 → | Aug 15, 4:16 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 25,000 | — | — | 0 | — | |
| Jul 15, 2016 AForm 4 → | Jul 19, 4:09 pm EDT | Elona Kogan Esq.Sr. V. P. - General Counsel | 300,000 | $7.13 | $1,426,000 | 100,000 | — | |
| Jul 13, 2016 MForm 4 → | Jul 14, 4:23 pm EDT | Paris PanayiotopoulosPresident and CEO, Director | 66,600 | — | — | 133,400 | — | |
| Jul 1, 2016 MForm 4 → | Jul 5, 4:07 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 61,422 | $3.88 | $238,585 | 0 | — | |
| Jun 27, 2016 MForm 4 → | Jun 29, 4:25 pm EDT | Hugh M ColeSVP, Chief Business Officer | 19,166 | — | — | 6,667 | — | |
| Jun 13, 2016 MForm 4 → | Jun 15, 4:19 pm EDT | Athanese LavidasDirector | 76,250 | $6.38 | $486,488 | 18,750 | — | |
| Jun 10, 2016 MForm 4 → | Jun 14, 6:13 pm EDT | Massimo RadaelliDirector | 108,569 | $5.38 | $584,596 | 18,750 | — | |
| Jun 6, 2016 AForm 4 → | Jun 8, 4:09 pm EDT | Jayne M. GanslerSenior V.P. Human Resources | 216,000 | $8.86 | $1,275,840 | 72,000 | — | |
| May 31, 2016 AForm 4 → | Jun 1, 4:54 pm EDT | Jennifer Lyn HerronExec V.P. Chief Comm'l Officer | 300,000 | $8.85 | $2,655,000 | 300,000 | — | |
| May 4, 2016 AForm 4 → | May 6, 4:20 pm EDT | Jules HaimovitzDirector | 75,000 | $6.65 | $498,750 | 75,000 | — | |
| May 4, 2016 AForm 4 → | May 6, 4:19 pm EDT | George BickerstaffDirector | 75,000 | $6.65 | $498,750 | 75,000 | — | |
| Apr 29, 2016 MForm 4 → | May 2, 5:33 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 17,334 | — | — | 0 | — | |
| Apr 29, 2016 MForm 4 → | May 2, 5:32 pm EDT | Maria E CantorSVP, Corporate Affairs | 13,334 | — | — | 0 | — | |
| Apr 29, 2016 MForm 4 → | May 2, 5:30 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 17,334 | — | — | 0 | — | |
| Apr 29, 2016 MForm 4 → | May 2, 5:29 pm EDT | Hugh M ColeSVP, Chief Business Officer | 17,334 | — | — | 0 | — | |
| Apr 29, 2016 MForm 4 → | May 2, 5:28 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 23,400 | — | — | 0 | — | |
| Apr 29, 2016 MForm 4 → | May 2, 5:26 pm EDT | Martin J DuvallEVP, CCO | 18,000 | — | — | 0 | — | |
| Mar 21, 2016 AForm 4 → | Mar 22, 4:00 pm EDT | Manmeet Singh SoniEVP, CFO & Treasurer | 550,000 | — | — | 550,000 | — | |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:03 pm EDT | Martin J DuvallEVP, CCO | 8,000 | — | — | 0 | — | |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:02 pm EDT | David L BersteinSVP, Chief IP Counsel | 4,750 | — | — | 0 | — | |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:02 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 8,000 | — | — | 0 | — | |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:02 pm EDT | Maria E CantorSVP, Corporate Affairs | 6,500 | — | — | 0 | — | |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:01 pm EDT | Timothy P ClacksonPresident, R&D, CSO | 10,833 | — | — | 0 | — | |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:01 pm EDT | Edward M FitzgeraldExecutive VP | 10,833 | — | — | 0 | — | |
| Mar 19, 2016 MForm 4 → | Mar 22, 4:01 pm EDT | Frank HaluskaSVP, Clinical R&D, CMO | 6,500 | — | — | 0 | — | |
| Mar 16, 2016 AMForm 4 → | Mar 18, 4:04 pm EDT | Hugh M ColeSVP, Chief Business Officer | 22,500 | $6.21 | $46,575 | 7,500 | — | |
| Mar 15, 2016 MForm 4 → | Mar 17, 4:45 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 3,750 | $1.30 | $4,875 | 0 | — | |
| Mar 7, 2016 AForm 4 → | Mar 9, 5:14 pm EST | Maria E CantorSVP, Corporate Affairs | 66,300 | $6.51 | $332,010 | 15,300 | — | |
| Mar 7, 2016 AForm 4 → | Mar 9, 5:14 pm EST | Frank HaluskaSVP, Clinical R&D, CMO | 78,000 | $6.51 | $390,600 | 18,000 | — | |
| Mar 7, 2016 AForm 4 → | Mar 9, 5:14 pm EST | Timothy P ClacksonPresident, R&D, CSO | 113,305 | — | — | 26,180 | — | |
| Mar 7, 2016 AForm 4 → | Mar 9, 5:14 pm EST | Thomas DesRosierEVP, General Counsel | 133,300 | — | — | 30,800 | — | |
| Mar 7, 2016 AForm 4 → | Mar 9, 5:13 pm EST | Martin J DuvallEVP, CCO | 113,305 | — | — | 26,180 | — | |
| Mar 7, 2016 AForm 4 → | Mar 9, 5:13 pm EST | Hugh M ColeSVP, Chief Business Officer | 101,400 | $6.51 | $507,780 | 23,400 | — | |
| Mar 7, 2016 AForm 4 → | Mar 9, 5:13 pm EST | Edward M FitzgeraldExecutive VP, CFO | 113,305 | $6.51 | $567,184 | 26,180 | — | |
| Mar 7, 2016 AForm 4 → | Mar 9, 5:08 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 78,000 | — | — | 18,000 | — | |
| Mar 1, 2016 AMForm 4 → | Mar 3, 8:12 pm EST | Edward M FitzgeraldExecutive VP, CFO | 57,750 | — | — | 38,500 | — | |
| Mar 1, 2016 AMForm 4 → | Mar 3, 8:08 pm EST | David L BersteinSVP, Chief IP Counsel | 57,750 | — | — | 38,500 | — | |
| Mar 1, 2016 AMForm 4 → | Mar 3, 8:07 pm EST | Martin J DuvallEVP, CCO | 57,750 | — | — | 38,500 | — | |
| Mar 1, 2016 AMForm 4 → | Mar 3, 8:00 pm EST | Maria E CantorSVP, Corporate Affairs | 57,750 | — | — | 38,500 | — | |
| Mar 1, 2016 AMForm 4 → | Mar 3, 8:00 pm EST | Timothy P ClacksonPresident, R&D, CSO | 57,750 | — | — | 38,500 | — | |
| Mar 1, 2016 AMForm 4 → | Mar 3, 7:59 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 57,750 | — | — | 38,500 | — | |
| Mar 1, 2016 AMForm 4 → | Mar 3, 7:58 pm EST | Frank HaluskaSVP, Clinical R&D, CMO | 57,750 | — | — | 38,500 | — | |
| Feb 18, 2016 MForm 4 → | Mar 30, 5:04 pm EDT | Thomas DesRosierEVP, General Counsel | 55,000 | — | — | 55,000 | — | late |
| Feb 1, 2016 AForm 4/A → | Feb 9, 5:31 pm EST | Jay R LamarcheDirector | 25,000 | $4.91 | $122,750 | 25,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 3, 5:31 pm EST | Alexander J DennerDirector | 25,000 | $4.91 | $122,750 | 25,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 3, 5:17 pm EST | Jay R LamarcheDirector | 25,000 | $4.91 | $122,750 | 25,000 | — | amended |
| Feb 1, 2016 AForm 4 → | Feb 3, 5:15 pm EST | Wayne WilsonDirector | 25,000 | $4.91 | $122,750 | 25,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 3, 5:08 pm EST | Athanese LavidasDirector | 25,000 | $4.91 | $122,750 | 25,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 3, 4:56 pm EST | Anna ProtopapasDirector | 25,000 | $4.91 | $122,750 | 25,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 3, 4:54 pm EST | Massimo RadaelliDirector | 25,000 | $4.91 | $122,750 | 25,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 3, 4:50 pm EST | Sarah J. SchlesingerDirector | 25,000 | $4.91 | $122,750 | 25,000 | — | |
| Feb 1, 2016 AForm 4 → | Feb 3, 4:47 pm EST | Norbert G RiedelDirector | 25,000 | $4.91 | $122,750 | 25,000 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:46 pm EST | Martin J DuvallEVP, CCO | 29,333 | — | — | 29,333 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:43 pm EST | Timothy P ClacksonPresident, R&D, CSO | 29,333 | — | — | 29,333 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:41 pm EST | Daniel M BollagSr. VP, Reg. Affairs & Quality | 29,333 | — | — | 29,333 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:39 pm EST | Frank HaluskaSVP, Clinical R&D, CMO | 29,333 | — | — | 29,333 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:38 pm EST | David L BersteinSVP, Chief IP Counsel | 29,333 | — | — | 29,333 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:37 pm EST | Edward M FitzgeraldExecutive VP, CFO | 29,333 | — | — | 29,333 | — | |
| Feb 1, 2016 MForm 4 → | Feb 3, 4:35 pm EST | Maria E CantorSVP, Corporate Affairs | 29,333 | — | — | 29,333 | — | |
| Jan 13, 2016 AForm 4 → | Jan 15, 4:35 pm EST | Paris PanayiotopoulosPresident and CEO, Director | 1,700,000 | $5.34 | $8,010,000 | 200,000 | — | |
| Dec 31, 2015 MForm 4 → | Jan 5, 2016, 5:41 pm EST | Harvey J M D BergerChairman & CEO, Director | 602,500 | — | — | 0 | — | |
| Sep 24, 2015 AMForm 4/A → | Sep 30, 4:14 pm EDT | David L BersteinSVP, Chief IP Counsel | 30,000 | — | — | 20,000 | — | |
| Sep 24, 2015 AMForm 4/A → | Sep 28, 6:35 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 30,000 | — | — | 20,000 | — | |
| Sep 24, 2015 AMForm 4 → | Sep 28, 6:14 pm EDT | Daniel M BollagSr. VP, Reg. Affairs & Quality | 30,000 | — | — | 20,000 | — | |
| Sep 24, 2015 AMForm 4 → | Sep 28, 6:09 pm EDT | Martin J DuvallEVP, CCO | 30,000 | — | — | 20,000 | — | |
| Sep 24, 2015 AMForm 4 → | Sep 28, 5:57 pm EDT | Maria E CantorSVP, Corporate Affairs | 30,000 | — | — | 20,000 | — | |
| Sep 24, 2015 AMForm 4 → | Sep 28, 5:50 pm EDT | Edward M FitzgeraldExecutive VP, CFO | 52,500 | — | — | 35,000 | — |